Skip to content

A clinical trial to comparatively evaluate budesonide versus fluticasone nebulisation for prevention of post operative sore throat

Comparative Evaluation of Budesonide and Fluticasone nebulisation in preventing Post operative Sore Throat - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072501
Enrollment
159
Registered
2024-08-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J99- Diseases of the respiratory system

Interventions

Intervention1: Comparative evaluation of Budesonide and fluticasone nebulisation in preventing post operative sore throat: Patients in Group B will be nebulised with Budesonide 500 mcg diluted to 5ml,

Sponsors

Dayanand Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Adult patient of age group 18 to 70 years. - American Society of Anaesthesiology (ASA) physical status (PS) 1,2,3 - BMI less than 35kg/m2. - Scheduled to undergo elective surgery lasting more than 2 hours, under General Anaesthesia (GA) using Endotracheal Tube (ETT).

Exclusion criteria

Exclusion criteria: - Patients who are uncooperative and unwilling to take part in study -Patient with history of preoperative sore throat or upper respiratory tract infection - Known allergy to budesonide or fluticasone - Patient already on budesonide or fluticasone treatment -Pregnant or lactating mothers -History of COPD or Asthma -Mallampati grade greater than 2 -Surgeries in prone position - Patients undergoing day care, bariatric, cardiac, nasal, oral, head and neck surgeries - Patient requiring throat pack -Obese patients BMI greater than 35kg/m2 - Patients with history of use of steroids or NSAIDS within 24 hrs of surgery -Patients having psychiaric illness and communication difficulties

Design outcomes

Primary

MeasureTime frame
To compare incidence, severity and duration of sore throat in all 3 groupsTimepoint: To compare incidence, severity and duration of sore throat at post op hours 0, 2, 4, 8, 12, 24

Secondary

MeasureTime frame
1. To compare occurance of postextubation cough and hoarseness of voice in all 3 groups 2. To compare side effect profile of both the drugsTimepoint: hoarseness of voice postoperatively at 0hour, 2hours, 4hours, 8hours,12 hours, 24 hours

Countries

India

Contacts

Public ContactManvinder kaur

Dayanand medical college and hospital

manvindermau@gmail.com8968779321

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026